학술논문
Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.
Document Type
article
Author
Sidbury, Robert; Davis, Dawn M; Cohen, David E; Cordoro, Kelly M; Berger, Timothy G; Bergman, James N; Chamlin, Sarah L; Cooper, Kevin D; Feldman, Steven R; Hanifin, Jon M; Krol, Alfons; Margolis, David J; Paller, Amy S; Schwarzenberger, Kathryn; Silverman, Robert A; Simpson, Eric L; Tom, Wynnis L; Williams, Hywel C; Elmets, Craig A; Block, Julie; Harrod, Christopher G; Begolka, Wendy Smith; Eichenfield, Lawrence F; American Academy of Dermatology
Source
Journal of the American Academy of Dermatology. 71(2)
Subject
Language
Abstract
Atopic dermatitis is a chronic, pruritic inflammatory dermatosis that affects up to 25% of children and 2% to 3% of adults. This guideline addresses important clinical questions that arise in atopic dermatitis management and care, providing recommendations based on the available evidence. In this third of 4 sections, treatment of atopic dermatitis with phototherapy and systemic immunomodulators, antimicrobials, and antihistamines is reviewed, including indications for use and the risk-benefit profile of each treatment option.